These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 15047780)

  • 1. Hepatitis C incidence--a comparison between injection and noninjection drug users in New York City.
    Fuller CM; Ompad DC; Galea S; Wu Y; Koblin B; Vlahov D
    J Urban Health; 2004 Mar; 81(1):20-4. PubMed ID: 15047780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience.
    Roy E; Boudreau JF; Boivin JF
    Drug Alcohol Depend; 2009 Jun; 102(1-3):158-61. PubMed ID: 19251382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injection of drug residue as a potential risk factor for HCV acquisition among Montréal young injection drug users.
    Roy E; Arruda N; Leclerc P; Haley N; Bruneau J; Boivin JF
    Drug Alcohol Depend; 2012 Nov; 126(1-2):246-50. PubMed ID: 22699096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy.
    Quaglio G; Lugoboni F; Pajusco B; Sarti M; Talamini G; Lechi A; Mezzelani P; Des Jarlais DC
    Clin Infect Dis; 2003 Jul; 37(1):33-40. PubMed ID: 12830406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia.
    Maher L; Jalaludin B; Chant KG; Jayasuriya R; Sladden T; Kaldor JM; Sargent PL
    Addiction; 2006 Oct; 101(10):1499-508. PubMed ID: 16968352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users.
    Bruneau J; Roy E; Arruda N; Zang G; Jutras-Aswad D
    Addiction; 2012 Jul; 107(7):1318-27. PubMed ID: 22248184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High hepatitis C virus prevalence and incidence among Canadian intravenous drug users.
    Roy E; Alary M; Morissette C; Leclerc P; Boudreau JF; Parent R; Rochefort J; Claessens C;
    Int J STD AIDS; 2007 Jan; 18(1):23-7. PubMed ID: 17326858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: implications for prevention policy and planning.
    Wand H; Spiegelman D; Law M; Jalaludin B; Kaldor J; Maher L
    Addiction; 2009 Dec; 104(12):2049-56. PubMed ID: 19804463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C infection among drug users in northern Thailand.
    Jittiwutikarn J; Thongsawat S; Suriyanon V; Maneekarn N; Celentano D; Razak MH; Srirak N; Vongchak T; Kawichai S; Thomas D; Sripaipan T; Netski D; Ananthakrishnan A; Nelson KE
    Am J Trop Med Hyg; 2006 Jun; 74(6):1111-6. PubMed ID: 16760529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indications of immune protection from hepatitis C infection.
    Aitken CK; Bowden S; Hellard M; Crofts N
    J Urban Health; 2004 Mar; 81(1):58-60. PubMed ID: 15047784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users.
    Miller CL; Johnston C; Spittal PM; Li K; Laliberté N; Montaner JS; Schechter MT
    Hepatology; 2002 Sep; 36(3):737-42. PubMed ID: 12198668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "I inject less as I have easier access to pipes": injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed.
    Leonard L; DeRubeis E; Pelude L; Medd E; Birkett N; Seto J
    Int J Drug Policy; 2008 Jun; 19(3):255-64. PubMed ID: 18502378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV seroconversion among never-injecting heroin users at baseline: no predictors identified other than starting injection.
    Bravo MJ; Vallejo F; Barrio G; Brugal MT; Molist G; Pulido J; Sordo L; de la Fuente L;
    Int J Drug Policy; 2012 Sep; 23(5):415-9. PubMed ID: 22421554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT).
    Garfein RS; Swartzendruber A; Ouellet LJ; Kapadia F; Hudson SM; Thiede H; Strathdee SA; Williams IT; Bailey SL; Hagan H; Golub ET; Kerndt P; Hanson DL; Latka MH;
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S4-17. PubMed ID: 17582705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004.
    Falster K; Kaldor JM; Maher L;
    J Urban Health; 2009 Jan; 86(1):106-18. PubMed ID: 18979201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999.
    Thorpe LE; Ouellet LJ; Levy JR; Williams IT; Monterroso ER
    J Infect Dis; 2000 Dec; 182(6):1588-94. PubMed ID: 11069228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High incidence of hepatitis C virus reinfection within a cohort of injecting drug users.
    Micallef JM; Macdonald V; Jauncey M; Amin J; Rawlinson W; van Beek I; Kaldor JM; White PA; Dore GJ
    J Viral Hepat; 2007 Jun; 14(6):413-8. PubMed ID: 17501762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities.
    Hagan H; Pouget ER; Williams IT; Garfein RL; Strathdee SA; Hudson SM; Latka MH; Ouellet LJ
    J Infect Dis; 2010 Feb; 201(3):378-85. PubMed ID: 20053137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
    Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
    Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.